VASCEPA DIN 02495244
Health Canada record
| Active ingredient(s) | ICOSAPENT ETHYL 1 G |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | C10AX06 OMEGA-3-TRIGLYCERIDES INCL. OTHER ESTERS AND ACIDS |
| Original market date | 07-Feb-2020 |
| Current status date | 07-Feb-2020 |
| Source | Health Canada DPD |
Establishment licence of the holder
HLS Therapeutics Inc — licence 3-002338, currently licensed, last inspection rating C (2025-01-16).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 23058 | 2019-12-30 | New Drug Submission (NDS) |
International API supply for ICOSAPENT ETHYL
12 active FDA Drug Master Files.
Request a quote for VASCEPA